Herrera, C <br/><br/>
Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.  [electronic resource] 

 -  Bone marrow transplantation  Mar 1997 
 - 545-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1700698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Child<br/>Colony-Forming Units Assay<br/>Culture Media, Serum-Free<br/>Cytotoxicity, Immunologic--drug effects<br/>Female<br/>Flow Cytometry<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Hematopoietic Stem Cell Transplantation<br/>Hematopoietic Stem Cells--cytology<br/>Humans<br/>Interleukin-2--pharmacology<br/>Killer Cells, Lymphokine-Activated--drug effects<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Neoplasms--immunology<br/>Recombinant Proteins--pharmacology